Skip to main content
. 2013 May 7;108(10):1998–2004. doi: 10.1038/bjc.2013.227

Table 2. Treatment and dose-limiting toxicities for each dose level (all cycles).

Tremelimumab, mg kg−1 PF-3512676, mg kg−1 Patients, n Dose-limiting toxicities, n
6
0.05
3
0
10
0.05
6
1
15
0.05
6
2
10
0.10
3
1
10 0.15 3 2